We thus analyzed whether there were any pathologic mutations at amino acid 30-42 of PrLZ in cancers by analyzing TCGA and COSMIC databases (https://cancer.sanger.ac.uk/cosmic/). The gene discussed is TPD52; the disease is cancer.